Biodesix, Inc. BDSX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $96.1M+8.6% | $88.5M+10.4% | $80.17M+4.7% | $76.56M+2.8% | $74.46M+4.4% | ||
| $12.42M+3.5% | $12M+3.9% | $11.55M+4.0% | $11.1M+6.8% | $10.39M+8.7% | ||
| $91.36M+4.4% | $87.55M+3.2% | $84.79M+2.0% | $83.09M+3.4% | $80.34M-0.1% | ||
| $121.03M+4.0% | $116.37M+3.2% | $112.73M+1.9% | $110.65M+3.3% | $107.08M+1.2% | ||
| -$24.94M+10.5% | -$27.87M+14.4% | -$32.56M+4.5% | -$34.1M-4.5% | -$32.61M+5.5% | ||
| -26%+5.5pp | -31.5%+9.1pp | -40.6%+3.9pp | -44.5%-0.7pp | -43.8%+4.6pp | ||
| $8.01M+3.8% | $7.72M+4.1% | $7.41M+0.4% | $7.38M-0.5% | $7.41M-10.2% | ||
| -$7.02M+5.0% | -$7.39M-5.9% | -$6.98M0.0% | -$6.98M+10.5% | -$7.81M+7.4% | ||
| -$31.96M+9.4% | -$35.27M+10.8% | -$39.54M+3.8% | -$41.08M-1.6% | -$40.42M+5.9% | ||
| -33.3%+6.6pp | -39.8%+9.5pp | -49.3%+4.3pp | -53.7%+0.6pp | -54.3%+5.9pp | ||
| -$2.48+22.3% | -$3.19+15.8% | -$3.79+6.0% | -$4.030.0% | -$4.03-52.1% | ||
| -$19.31M+13.0% | -$22.2M+17.2% | -$26.82M+5.1% | -$28.28M-5.4% | -$26.82M+6.6% | ||
| -20.1%+5.0pp | -25.1%+8.4pp | -33.5%+3.5pp | -36.9%-0.9pp | -36%+4.3pp | ||
| -$24.94M+10.5% | -$27.87M+14.4% | -$32.56M+4.5% | -$34.1M-4.5% | -$32.61M+5.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
